4.7 Review

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia-Systematic Review and Metanalysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Physiology

Potential biomarkers for late-onset and term preeclampsia: A scoping review

Luhao Han et al.

Frontiers in Physiology (2023)

Review Obstetrics & Gynecology

Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders

Sarosh Rana et al.

Summary: Preeclampsia is a serious complication of pregnancy that can lead to morbidity and mortality for both the mother and fetus. Abnormal levels of circulating angiogenic factors released from the placenta are believed to be responsible for the symptoms of preeclampsia. Measuring these angiogenic biomarkers in the blood can help clinicians diagnose and predict preeclampsia. Additionally, these biomarkers are useful in studying the mechanisms of related disorders of placental implantation.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Review Obstetrics & Gynecology

The evolution of the diagnostic criteria of preeclampsia-eclampsia

Michael S. Tanner et al.

Summary: With the improved understanding of preeclampsia's pathophysiology, its diagnostic criteria have evolved. This review critically evaluates the evidence that has influenced the development of the criteria, focusing on how they have changed over time and discussing key debates and potential future directions. The importance of considering factors such as age and weight in blood pressure thresholds, the effectiveness of existing blood pressure and proteinuria thresholds, and the potential benefits of using flow-charts and decision trees are among the topics examined.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Review Obstetrics & Gynecology

Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways

Christopher W. G. Redman et al.

Summary: Preeclampsia evolves in 2 stages, with a placental problem generating signals to the mother and causing a range of responses. Early-onset preeclampsia is associated with poor placentation and lasts for several months, resulting in fetal growth restriction. Late-onset preeclampsia is part of a common process in all pregnancies, as the placental function declines with increasing chorionic villous packing. The most relevant feature of preeclampsia is syncytiotrophoblast stress, which can be detected in the maternal circulation. Soluble fms-like tyrosine kinase-1 is the best-known biomarker for preeclampsia.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Review Obstetrics & Gynecology

The etiology of preeclampsia

Eunjung Jung et al.

Summary: This article reviews the potential etiologies of preeclampsia, including uteroplacental ischemia, microbial infection, and SARS-CoV-2 infection. It also discusses the association between gestational diabetes mellitus, maternal obesity, autoimmunity, fetal diseases, endocrine disorders and preeclampsia.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Review Medicine, General & Internal

Preeclampsia

Laura A. Magee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation

Anne Dathan-Stumpf et al.

Summary: This study investigates the impact of the sFlt-1/PlGF ratio in predicting short-term risk of preeclampsia on clinical utility and healthcare resource utilisation. The findings suggest that the routine use of the sFlt-1/PlGF ratio may result in shorter hospitalisations and potential economic benefits.

PLOS ONE (2022)

Review Multidisciplinary Sciences

Blood biomarkers to predict the onset of pre-eclampsia: A systematic review and meta-analysis

Marianna Danielli et al.

Summary: This is the most comprehensive and up to date systematic review and meta-analysis on blood biomarkers for the early prediction of pre-eclampsia, highlighting the urgent need for further research to identify blood biomarkers that could predict the development of pre-eclampsia.

HELIYON (2022)

Article Cardiac & Cardiovascular Systems

Increased Uric Acid, Gamma-Glutamyl Transpeptidase and Alkaline Phosphatase in Early-Pregnancy Associated With the Development of Gestational Hypertension and Preeclampsia

Yequn Chen et al.

Summary: The study showed that elevated levels of uric acid, GGT, and ALP in early pregnancy are independent risk factors for gestational hypertension and preeclampsia, positively associated with both blood pressure levels and HDP incidence.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Obstetrics & Gynecology

Gestational Hypertension and Preeclampsia

Jimmy Espinoza et al.

OBSTETRICS AND GYNECOLOGY (2020)

Article Obstetrics & Gynecology

Maternal serum AMP-activated protein kinase levels in mild and severe preeclampsia

Nadiye Koroglu et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2019)

Article Obstetrics & Gynecology

Dysregulation of circulating sTie2 and sHER2 in HIV-infected women with preeclampsia

Mduduzi Mazibuko et al.

HYPERTENSION IN PREGNANCY (2019)

Article Obstetrics & Gynecology

Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women

J. S. R. Machado et al.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2019)

Review Medicine, General & Internal

Pre-eclampsia: pathophysiology and clinical implications

Graham J. Burton et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Obstetrics & Gynecology

Creatine kinase and blood pressure in women with a history of early-onset preeclampsia

Deborah L. Horjus et al.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2019)

Article Obstetrics & Gynecology

First trimester placental vascularization and angiogenetic factors are associated with adverse pregnancy outcome

Johanna E. W. Leijnse et al.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2018)

Article Obstetrics & Gynecology

Serum levels of ET-1, M30, and angiopoietins-1 and-2 in HELLP syndrome and preeclampsia compared to controls

Savas Karakus et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)

Article Peripheral Vascular Disease

Combination of serum angiopoietin-2 and uterine artery Doppler for prediction of preeclampsia

Ploynin Puttapitakpong et al.

HYPERTENSION RESEARCH (2016)

Review Urology & Nephrology

Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines

Elizabeth Phipps et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Medicine, General & Internal

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia

Harald Zeisler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Obstetrics & Gynecology

Angiopoietin 1 and 2 serum concentrations in first trimester of pregnancy as biomarkers of adverse pregnancy outcomes

Francisco J. Schneuer et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)

Article Obstetrics & Gynecology

Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester

Shin Young Kim et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2013)

Article Obstetrics & Gynecology

Angiopoietin-2: A Promising Indicator for the Occurrence of Severe Preeclampsia

Soo Yeon Han et al.

HYPERTENSION IN PREGNANCY (2012)

Article Obstetrics & Gynecology

Bone turnover in preeclampsia-complicated pregnancy in North Indian women

Ashok Kumar et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2012)

Article Endocrinology & Metabolism

Decreased Circulating Soluble Tie2 Levels in Preeclampsia May Result from Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling

Joyce F. Sung et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Review Obstetrics & Gynecology

Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia

Mitsuko Furuya et al.

JOURNAL OF PREGNANCY (2011)

Article Endocrinology & Metabolism

Maternal Serum Angiopoietin-1 and-2 and Tie-2 in Early Pregnancy Ending in Preeclampsia or Intrauterine Growth Retardation

Elina Leinonen et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Article Peripheral Vascular Disease

Angiopoietin-1/Angiopoietin-2 Ratio for Prediction of Preeclampsia

Marie Bolin et al.

AMERICAN JOURNAL OF HYPERTENSION (2009)

Article Obstetrics & Gynecology

Plasma level of soluble c-Met is tightly associated with the clinical risk of preeclampsia

Xin Zeng et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)

Review Obstetrics & Gynecology

Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2

Francesca Gotsch et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)

Article Hematology

VEGF induces Tie2 shedding via a phosphoinositide 3-Kinase/Akt-Dependent pathway to modulate Tie2 signaling

Clarence M. Findley et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Urology & Nephrology

Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia

Kumiko Hirokoshi et al.

NEPHRON CLINICAL PRACTICE (2007)

Article Hematology

Plasma markers of angiogenesis in pregnancy induced hypertension

SK Nadar et al.

THROMBOSIS AND HAEMOSTASIS (2005)

Article Peripheral Vascular Disease

Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia

K Hirokoshi et al.

AMERICAN JOURNAL OF HYPERTENSION (2005)